From the Department of Headlines that caused a double take....
Abbott Labs to Acquire Kos Abbott Labs agreed to pay $3.7 billion for Kos Pharmaceuticals, which makes a drug that raises so-called good cholesterol.
Tags: blogosphere, /Pharmaceuticals